These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29431121)

  • 21. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis.
    Huang Q; Ma Y; Adebayo A; Pope RM
    Arthritis Rheum; 2007 Jul; 56(7):2192-201. PubMed ID: 17599732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 induction.
    Spurlock CF; Tossberg JT; Matlock BK; Olsen NJ; Aune TM
    Arthritis Rheumatol; 2014 Nov; 66(11):2947-57. PubMed ID: 25077978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.
    Neurath MF; Hildner K; Becker C; Schlaak JF; Barbulescu K; Germann T; Schmitt E; Schirmacher P; Haralambous S; Pasparakis M; Meyer Zum Büschenfelde KH; Kollias G; Märker-Hermann E
    Clin Exp Immunol; 1999 Jan; 115(1):42-55. PubMed ID: 9933419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
    Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
    Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
    Parker A; Izmailova ES; Narang J; Badola S; Le T; Roubenoff R; Ginsburg GS; Maier A; Coblyn JS; Shadick NA; Weinblatt ME
    J Rheumatol; 2007 Sep; 34(9):1817-22. PubMed ID: 17696278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis.
    Fuentelsaz-Romero S; Barrio-Alonso C; García Campos R; Torres Torresano M; Muller IB; Triguero-Martínez A; Nuño L; Villalba A; García-Vicuña R; Jansen G; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A
    Front Immunol; 2021; 12():776879. PubMed ID: 34804067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation.
    Thornton CC; Al-Rashed F; Calay D; Birdsey GM; Bauer A; Mylroie H; Morley BJ; Randi AM; Haskard DO; Boyle JJ; Mason JC
    Ann Rheum Dis; 2016 Feb; 75(2):439-48. PubMed ID: 25575725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance.
    Kim HY; Lee SW; Park SY; Baek SH; Lee CW; Hong KW; Kim CD
    Life Sci; 2012 Sep; 91(7-8):250-7. PubMed ID: 22820172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G protein-coupled receptor 39 activation alleviates oxidized low-density lipoprotein-induced macrophage inflammatory response, lipid accumulation and apoptosis by inducing A20 expression.
    Chen L; Fang Z; Wang X; Sun X; Ge X; Cheng C; Hu H
    Bioengineered; 2021 Dec; 12(1):4070-4080. PubMed ID: 34288802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
    Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
    Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate.
    Miranda-Carús ME; Balsa A; Benito-Miguel M; Pérez de Ayala C; Martín-Mola E
    J Immunol; 2004 Jul; 173(2):1463-76. PubMed ID: 15240743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of methotrexate in combination with anti-tumor necrosis factor-alpha therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis.
    Matsuno H; Yoshida K; Ochiai A; Okamoto M
    J Rheumatol; 2007 Dec; 34(12):2326-33. PubMed ID: 18050387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.
    Xiao Z; Juan L; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X
    Hum Vaccin Immunother; 2015; 11(4):938-45. PubMed ID: 25763999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.